Most Recent
Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.
The High Court will weigh in on the relevance of reputation in passing off claims, taking up an appeal by Bed Bath N’ Table of a finding that rival retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
The Full Court has poured cold water on Vittoria Cantarella's hopes of reviving its ‘Oro’ trade marks, finding a judge did not err in concluding the marks were already used by another coffee maker.
The makers of Grand Theft Auto have largely succeeded in a copyright case against the developer behind the "Infamous Mod" -- a hack that alters the capabilities of players in the online version of the top-selling game.
Home retailer Bed Bath N’ Table has asked the High Court to reverse a Full Court judgment that found retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
Debt management business Solve My Debt Now will admit liability in action by the Australian Securities and Investments Commission alleging customers were worse off after using its services.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
In the second test of the new design and distribution obligations under the Corporations Act, ASIC is seeking a $20 million penalty against the provider of the Kraken crypto exchange.
In a loss for Bed Bath N' Table, the Full Court has overturned a finding that homewares retailer House engaged in misleading and deceptive conduct by setting up its 'Bed & Bath' stores.
Gaming giant Aristocrat has settled a suit brought against its former head of design, who admitted to copying a "substantial" number of documents containing the company's sensitive trade secrets.